Subtype
Benign Lymphatic Vessel Neoplasm
CI-CAN-00001908Explore in graph →
Non-malignant4 active trials
- NCIt
- C6524
Loading cancer entity…
Subtype
CI-CAN-00001908Explore in graph →
Clinical trials
11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00975819 | Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies | completed | Phase 2 | 61 | Denise Martin AdamsOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT06943703 | Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma | completed | — | 809 | National Children's Hospital, VietnamOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT05050149 | Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations | completed | Phase 2 | 12 | Palvella Therapeutics, Inc.INDUSTRY | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06257719 | Clinical Characteristics of Lymphatic Malformations |
Data updated 22 days agoSource updated Jan 6, 2026source: clinicaltrials
| completed |
| — |
| 320 |
| West China HospitalOTHER |
| 1 |
| Feb 14, 2024 |
| clinicaltrials |
| NCT01290484 | A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations | completed | Phase 1 / Phase 2 | 7 | Stanford UniversityOTHER | 1 | Jun 19, 2015 | clinicaltrials |